Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
about
Recent advances in prenatal genetic screening and testingRepeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusionAnalysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral centerAn Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18.Incidence of X and Y Chromosomal Aneuploidy in a Large Child Bearing PopulationImproving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases.Non-invasive Prenatal Testing (NIPT): Better Meet an Expert!: The Case of a Late Detected Trisomy 13 Reveals Structural Problems in NIPT Counselling and Highlights Substantial Risks for the Reproductive Autonomy.Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage.Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and AustriaReport on noninvasive prenatal testing: classical and alternative approaches.Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results.Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage.Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories.Clinical implementation of NIPT - technical and biological challenges.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNAHow to perform transabdominal chorionic villus sampling: a practical guideline.Current status of non-invasive prenatal testing in Japan.The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon.Fetal aneuploidy screening with cell-free DNA in late gestation.Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y.Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing Platform.Discordant non-invasive prenatal testing (NIPT) - a systematic review.Lost in Translation? Ethical Challenges of Implementing a New Diagnostic Procedure.Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States.Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions.
P2860
Q28071888-188AF631-3CEC-4349-8C15-A436C6892E32Q33437396-238C711B-06F2-49A8-B719-21C1361EF9ABQ35065456-725DFBB7-9352-4686-B8AE-1173D81703F5Q35552815-BDC8B9B6-62F8-4F00-B6DC-5049347E3869Q35649161-9221A06E-AA4D-451E-A699-D9B8964072DBQ35686965-52EAB0D3-8DE2-4319-BF13-1EECD5C560CBQ35763064-0883F847-C758-4658-B37A-D3E1971F3450Q36101039-79F0F6C1-7530-40C2-A97D-68398D55D5C3Q36293841-04A9A1BB-D58E-4E56-A93F-962D6C7101FDQ36762710-D05FA507-30FC-4AC1-A625-C96CD8098241Q36777378-C090BD23-A2E6-451A-8F8B-2C9AB5E93C2AQ36895493-EC8ACEC4-1F36-4099-9C18-5D2F584F4E1DQ37240193-3A057BF9-2696-4631-A642-E42917BC007BQ37255859-70B9223F-EE08-4573-8BCA-18F423B2D17AQ37320217-CA54B222-05E8-4D6B-8D49-943AAAD783FFQ37340281-3BB8CD05-A77A-41FD-948D-926A8F2AA8D9Q37418057-2D246287-7DDD-4920-89AB-938A7277B4D7Q37472073-5C303E83-302F-4E50-9097-8B534163EA6FQ37745036-D0EAA43C-91E1-4D5E-A103-F915543AFBE2Q38262952-A0667EC2-9047-460F-95F4-99923A348E1CQ38418240-3B720AFA-692F-445D-ADE0-1CA3D15D3133Q38549770-C30221CD-9B47-4197-B43B-7E20081E553EQ38587244-702D6BD8-0B85-4CF2-8967-6C9CCFFEFB07Q38740942-CB9A3B25-9527-43EF-9B7B-6469B2FD504CQ38760100-1797E6FA-0973-4528-A561-BAA5ADECB3D1Q38819938-833233D2-ED85-49EB-8114-04AD728D091BQ38860845-937FB8CD-F38A-4E28-B88E-CE67244073EFQ38895114-0F2B976E-80B0-4726-BF47-974BB6F126F7Q38928166-5D8E52F5-1382-4CBD-9DBD-BF9CAE17F317Q38973930-632631FE-36E2-4BDD-9EBF-94D6CBAAD14AQ39223783-C8159F54-D24A-425D-A1FF-C8069672D31DQ39278884-0116A6D8-A563-488E-8EDE-461CA2FA02ADQ39387768-8FC51A34-1390-40E4-A101-73E672BD140DQ39641895-E47549CA-E2FB-493C-B804-B64DFCD9E8BCQ40950309-CE87F077-D480-47E9-AB50-8EA14263D0C6Q41235376-C644539E-C087-4F4C-B3AC-9D5D1F6196E6Q41566460-E9252613-1F94-4BD1-B361-ACD83F2835DDQ41829533-1513A573-1614-4954-B643-3C944D35EBD6Q46058669-EE05F0E5-3BD6-4E51-86F7-C414F8CDF9BBQ46081566-ACEE2A43-800C-4AA0-97B1-BB2D5E81B13D
P2860
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical experience and follow ...... e prenatal aneuploidy testing.
@ast
Clinical experience and follow ...... e prenatal aneuploidy testing.
@en
Clinical experience and follow ...... e prenatal aneuploidy testing.
@nl
type
label
Clinical experience and follow ...... e prenatal aneuploidy testing.
@ast
Clinical experience and follow ...... e prenatal aneuploidy testing.
@en
Clinical experience and follow ...... e prenatal aneuploidy testing.
@nl
prefLabel
Clinical experience and follow ...... e prenatal aneuploidy testing.
@ast
Clinical experience and follow ...... e prenatal aneuploidy testing.
@en
Clinical experience and follow ...... e prenatal aneuploidy testing.
@nl
P2093
P1476
Clinical experience and follow ...... e prenatal aneuploidy testing.
@en
P2093
Allison Ryan
Bernhard Zimmermann
Charles M Strom
Kirsten J Curnow
Matthew Hill
Matthew Rabinowitz
Megan P Hall
Melissa Stosic
Milena Banjevic
Paula L Kolacki
P304
527.e1-527.e17
P356
10.1016/J.AJOG.2014.08.006
P407
P577
2014-08-08T00:00:00Z